Catecholamine secretory traits were significantly heritable, as were stress-induced blood pressure changes. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis. In the tyrosine hyroxylase promoter, significant associations were found for urinary catecholamine excretion and for blood pressure response to stress. TH promoter haplotype 2 (TGGG) showed pleiotropy, increasing both norepinephrine excretion and blood pressure during stress. In hypertension, 2 independent case-control studies (1,266 subjects with 53% women and 927 subjects with 24% women) replicated the effect of C-824T in the determination of blood pressure. Chromogranin A (CHGA) plays a fundamental role in the biogenesis of catecholamine secretory granules. Changes in the storage and release of CHGA in clinical and experimental hypertension prompted us to study whether genetic variation at the CHGA locus might contribute to alterations in autonomic function, and hence hypertension and its target organ consequences such as hypertensive kidney disease (nephrosclerosis). Systematic polymorphism discovery across the human CHGA locus revealed such regulatory regions as the proximal promoter and 3'-UTR. In chromaffin cell-transfected CHGA 3'-UTR and promoter/luciferase reporter plasmids, the functional consequences of the regulatory/non-coding allelic variants were documented. Variants in both the proximal promoter and the 3'-UTR displayed statistical associations with hypertension and hypertensive end stage renal disease. Therefore, I would like to review the common genetic variation in TH and CHGA as a cause of inter-individual variation in sympathetic activity, and ultimately blood pressure and hypertensive kidney disease.
Introduction
Chromogranin A (CHGA) is the major protein co-stored and co-released with catecholamines from secretory vesicles in adrenal medulla and postganglionic sympathetic axons 1) . CHGA is required for the formation of catecholamine secretory vesicles in chromaffin cells 2) . CHGA is also a pro-hormone that gives rise to biologically active peptides such as the dysglycemic peptide pancreastatin 3) , the antimicrobial peptide chromacin 4) , the vasodilator vasostatin, and catestatin that acts to inhibit catecholamine release 5, 6) . Over the past 20 years, phenotypic links between CHGA and hereditary (essential, idiopathic, and genetic) human 7, 8, 9) hypertension have been repeatedly observed. Increased serum CHGA has been detected not only in patients with essential hypertension 8) but also hypertensive consequences such as cardiac or renal failure 7) .
Researchers observed parallel findings on CHGA secretion and autonomic stress responses in humans 10, 11) , suggesting that an optimal amount of CHGA may be required to establish appropriate catecholamine storage and release, Copyright © 2013 The Korean Society of Electrolyte Metabolism and hence BP homeostasis. I will concentrate on polymorphism discovery at specific points in the catecholamine biosynthetic pathway ( Fig. 1) , especially tyrosine hydroxylase (TH), as outlined below, and link polymorphism to rigorously defined human phenotypes, both "intermediate" phenotypes in twin pairs (Fig. 2 ) and ultimate disease phenotypes (hypertension and hypertensive kidney disease). .
From Genomic Researches to Clinical Investigations
A common (27% allele frequency) genetic variant in the CHGA 3'-UTR (C+ 87T; rs7610) was strongly associated with human essential hypertension, accounting for up to 12/9 mmHg of BP in men, or 1.9/1.2% of population SBP/DBP variance, especially in males 13) . The 3'-UTR variant also predicts environmental stress induced increments in blood pressure: the same allele (+87T) that diminished basal BP in the population also decreased the SBP response to stress by 12 mmHg (p=0.017), and the response was smaller in women (by 6 mmHg, p=0.009), suggesting a mechanism for the early effects of the gene on a pathogenic series of events eventuating in sustained blood pressure elevation 13) . The 3'-UTR variant is in a region . The UCSD Twin Project allows to quantify h 2 using the classical human twin design. In a study related to this project, 4 common promoter variants in TH were powerful predictors of both biochemical (Fig. 3 ) and physiological traits (Fig. 4) . In particular, common promoter variants C-824T and A-581G were strong predictors of both catecholamine excretion (Fig. 3 ) and the BP response to environmental stress (Fig. 4) . TH promoter haplotypes (e.g., haplotype 2, TGGG) coordinately affected both biochemical traits and physiological stress traits in an illustration of pleiotropy, confirmed by bivariate analysis in SOLAR (Fig. 5) .
As an initial approach to genetic effects on the complex trait of hypertension, Ernie Beutler (Scripps Clinic) et al.
conducted a relatively unbiased ascertainment of subjects with the most extreme DBPs in a San Diego primary care population; the results were already published in Hypertension 16) . They illustrate this population-based case/control study, in which >1,200 subjects were drawn from
Copyright © 2013 The Korean Society of Electrolyte Metabolism In African-Americans with a clinical diagnosis of hypertensive kidney disease (or nephrosclerosis) 17) , genetic variation at CHGA predicts risk for developing the trait, and the peak effect lies in haplotypes spanning the 3'-end of the gene. They then found that CHGA polymorphism predicted the occurrence of hypertensive kidney disease in African-Americans with the peak risk conferred by variation in the 3'-region of the gene 17) . In this case/control study of hypertensive kidney disease, 3'-UTR variation was associated with ESRD 17) , while promoter variation resulting in alterations of the nuclear hormone receptor trans-activation may influence blood pressure 12) .
In subjects from the NIDDK AASK (African-American Study of Kidney Disease and Hypertension) trial, the chronic decline rate of GFR was influenced by genetic variation at CHGA, with the most prominent effect (p=0.006) from haplotype-1 in the 3'-haplotype block, spanning 3'-UTR C+ 87T/rs7610 18) . The effect was also seen for diploid haplotype pairs in that block (p=0.007) 18) . Finally, mechanistic studies were undertaken initiated by the clue that CHGA promoter variation predicted circulating endothelin-1. In cultured endothelial cells, CHGA triggered co-release of not only the vasoconstrictor and pro-fibrotic endothelin-1, but also the pro-coagulant von Willebrand Factor and the pro-angiogenic angiopoietin-2 18) . These findings, coup led with stimulation of endothelin-1 release from glomerular capillary endothelial cells by CHGA, suggest a plausible mechanism whereby genetic variation at the CHGA locus eventuates in alterations in human kidney function.
Conclusion
Thus, common genetic variation across the human CHGA and TH locus is associated with hypertension and hyper-
